ANXA1 levels were reduced in the peripheral plasma of patients with behavioral variants of AD and showed a correlation between ANXA1 and the production and abatement of its peripheral inflammatory mediators (Fraga et al., 2019). Here, ANXA1 is linked to Alzheimer disease.